Friday, October 09, 2015
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

John McManamy's Posts

My Last Post: Thank You, Dear Associates, Thank You, Dear Readers

Farewell, readers …


With this post, my 10-year relationship with HealthCentral comes to a close. I first began writing for HealthCentral in the fall of 2005. I owe a great debt of gratitude to Bill Allman who recruited me, for his guidance and encouragement, and for his professionalism and vision in building a health... Read moreChevron

You and Your Moods: A New Book and a Novel Look at Bipolar, One Month Away From Publication

Last week, I finished my draft to a book I am writing on bipolar. The book is to be part of a six-book series that I intend to self-publish and update regularly. The series will be called The Bipolar Expert Series. By bipolar expert, I am talking about you. My goal is to make you an expert patient.


Back in 2006, I... Read moreChevron

When Research Becomes Relevant: Looking at CREST.BD

A couple of years ago, I came across a bipolar research organization, founded in 2007 and based in Vancouver, BC, called CREST.BD. Thanks to funding from the Canadian Institutes of Health Research (CIHR), part of Health Canada, the organization is poised... Read moreChevron

Concerning Wellness: Encouraging Results From a Pilot Study

“Wellness” is not a topic one expects to come across at psychiatric conferences. The emphasis is always on illness and its treatments. “When I was young,” Saundra Jain, a San Antonio-based psychotherapist let us know, “wellness was never mentioned.”


The venue was - a psychiatric... Read moreChevron

J&J and VW: Tale of Two Corporate Scandals

The last couple of weeks have seen the breaking of two major corporate scandals. The first involved the pharmaceutical giant Johnson & Johnson aggressively marketing its antipsychotic medication Risperdal to the elderly and the very young, despite the obvious risks. The company pleaded guilty to a crime and wound up paying $2 billion in... Read moreChevron